Renee D. Gala, EVP & Chief Financial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $131.75 ($791K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Open-market sale of $790k JAZZ by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2022-12-22 | $422K | — | Filing → |
| TBPH | SELL | 2018-08-16 | $2.3M | — | Filing → |
| TBPH | SELL | 2018-05-22 | $243K | — | Filing → |